Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA)

被引：20

作者：

Alderson, D. ^{[1
]}

Bundred, J. ^{[1
]}

Evans, R. P. T. ^{[1
]}

Gossage, J. ^{[1
]}

Griffiths, E. A. ^{[1
]}

Jefferies, Byy ^{[1
]}

Kamarajah, S. K. ^{[1
]}

McKay, S. ^{[1
]}

Mohamed, I ^{[1
]}

Nepogodiev, D. ^{[1
]}

Siaw-Acheampong, K. ^{[1
]}

Singh, P. ^{[1
]}

van Hillegersberg, R. ^{[1
]}

Vohra, R. ^{[1
]}

Wanigasooriya, K. ^{[1
]}

Whitehouse, T. ^{[1
]}

Gjata, A. ^{[1
]}

Moreno, J., I ^{[1
]}

Takeda, F. R. ^{[1
]}

Kidane, B. ^{[1
]}

Castro, Guevara R. ^{[1
]}

Harustiak, T. ^{[1
]}

Bekele, A. ^{[1
]}

Kechagias, A. ^{[1
]}

Gockel, I ^{[1
]}

Kennedy, A. ^{[1
]}

Da Roit, A. ^{[1
]}

Bagajevas, A. ^{[1
]}

Azagra, J. S. ^{[1
]}

Mahendran, H. A. ^{[1
]}

Mejia-Fernandez, L. ^{[1
]}

Wijnhoven, B. P. L. ^{[1
]}

El Kafsi, J. ^{[1
]}

Sayyed, R. H. ^{[1
]}

Sousa, M. ^{[1
]}

Sampaio, A. S. ^{[1
]}

Negoi, I ^{[1
]}

Blanco, R. ^{[1
]}

Wallner, B. ^{[1
]}

Schneider, P. M. ^{[1
]}

Hsu, P. K. ^{[1
]}

Isik, A. ^{[1
]}

Gananadha, S. ^{[1
]}

Wills, V ^{[1
]}

Devadas, M. ^{[1
]}

Duong, C. ^{[1
]}

Talbot, M. ^{[1
]}

Hii, M. W. ^{[1
]}

Jacobs, R. ^{[1
]}

Andreollo, N. A. ^{[1
]}

机构：

[1] Queen Elizabeth Hosp Birmingham, Dept Upper Gastrointestinal Surg, Birmingham, England

来源：

ANNALS OF SURGERY | 2023年 / 277卷 / 05期

关键词：

CROSS; esophagectomy; FLOT; neoadjuvant therapy; outcomes; RANDOMIZED CLINICAL-TRIAL; PHASE-III TRIAL; GASTROESOPHAGEAL JUNCTION; PERIOPERATIVE CHEMOTHERAPY; PULMONARY-FUNCTION; CHEMORADIOTHERAPY; CANCER; SURGERY; COMPLICATIONS; MORTALITY;

D O I：

10.1097/SLA.0000000000005394

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Objective: This study aimed to compare the postoperative and pathological outcomes between carboplatin, paclitaxel, radiotherapy (CROSS) and 5-FU, leucovorine, oxaliplatin and docetaxel (FLOT) in esophageal adenocarcinoma (EAC) patients from an international, multicenter cohort. Summary of Background Data: Ongoing debate exists around optimum approach to locally advanced EAC, with proponents for perioperative chemotherapy, such as FLOT, or multimodal therapy, in particular the CROSS regimen. Methods: Patients undergoing CROSS (n = 350) and FLOT (n = 368), followed by curative esophagectomy for EAC were identified from the Oesophagogastric Anastomosis Audit. Results: The 90-day mortality was higher after CROSS than FLOT (5% vs 1%, P = 0.005), even on adjusted analyses [odds ratio (OR): 3.97, confidence interval (CI)(95%): 1.34-13.67]. Postoperative mortality in CROSS were related to higher pulmonary (74% vs 60%) and cardiac complications (42% vs 20%) compared to FLOT. CROSS was associated with higher pathologic complete response (pCR) rates (18% vs 10%, P = 0.004) and margin-negative resections (93% vs 76%, P < 0.001) compared with FLOT. On adjusted analyses, CROSS was associated with higher pCR rates (OR: 2.05, CI95%: 1.26-3.34) and margin-negative resections (OR: 4.55, CI95%: 2.70-7.69) compared to FLOT. Conclusions: This study provides real-world data CROSS was associated with higher 90-day mortality than FLOT, related to cardio-pulmonary complications with CROSS. These warrant a further review into causes and mechanisms in selected patients, and at minimum suggest the need for strict radiation therapy quality assurance. Research into impact of higher pCR rates and R0 resections with CROSS compared to FLOT on long-term survival is needed.

引用

页码：E1026 / E1034

页数：9

共 50 条

[1] Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer [J].

Abou-Jawde, RM ;

Mekhail, T ;

Adelstein, DJ ;

Rybicki, LA ;

Mazzone, PJ ;

Caroll, MA ;

Rice, TW .

CHEST, 2005, 128 (01) :250-255

[2] Esophageal and Esophagogastric Junction Cancers, Version 1.2015 [J].

Ajani, Jaffer A. ;

D'Amico, Thomas A. ;

Almhanna, Khaldoun ;

Bentrem, David J. ;

Besh, Stephen ;

Chao, Joseph ;

Das, Prajnan ;

Denlinger, Crystal ;

Fanta, Paul ;

Fuchs, Charles S. ;

Gerdes, Hans ;

Glasgow, Robert E. ;

Hayman, James A. ;

Hochwald, Steven ;

Hofstetter, Wayne L. ;

Ilson, David H. ;

Jaroszewski, Dawn ;

Jasperson, Kory ;

Keswani, Rajesh N. ;

Kleinberg, Lawrence R. ;

Korn, W. Michael ;

Leong, Stephen ;

Lockhart, A. Craig ;

Mulcahy, Mary F. ;

Orringer, Mark B. ;

Posey, James A. ;

Poultsides, George A. ;

Sasson, Aaron R. ;

Scott, Walter J. ;

Strong, Vivian E. ;

Varghese, Thomas K., Jr. ;

Washington, Mary Kay ;

Willett, Christopher G. ;

Wright, Cameron D. ;

Zelman, Debra ;

McMillian, Nicole ;

Sundar, Hema .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (02) :194-227

[3] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Homann, Nils ;

Pauligk, Claudia ;

Goetze, Thorsten O. ;

Meiler, Johannes ;

Kasper, Stefan ;

Kopp, Hans-Georg ;

Mayer, Frank ;

Haag, Georg Martin ;

Luley, Kim ;

Lindig, Udo ;

Schmiegel, Wolff ;

Pohl, Michael ;

Stoehlmacher, Jan ;

Folprecht, Gunnar ;

Probst, Stephan ;

Prasnikar, Nicole ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Trojan, Joerg ;

Koenigsmann, Michael ;

Martens, Uwe M. ;

Thuss-Patience, Peter ;

Egger, Matthias ;

Block, Andreas ;

Heinemann, Volker ;

Illerhaus, Gerald ;

Moehler, Markus ;

Schenk, Michael ;

Kullmann, Frank ;

Behringer, Dirk M. ;

Heike, Michael ;

Pink, Daniel ;

Teschendorf, Christian ;

Loehr, Carmen ;

Bernhard, Helga ;

Schuch, Gunter ;

Rethwisch, Volker ;

von Weikersthal, Ludwig Fischer ;

Hartmann, Joerg T. ;

Kneba, Michael ;

Daum, Severin ;

Schulmann, Karsten ;

Weniger, Joerg ;

Belle, Sebastian ;

Gaiser, Timo ;

Oduncu, Fuat S. ;

Guentner, Martina ;

Hozaeel, Wael ;

Reichart, Alexander .

LANCET, 2019, 393 (10184) :1948-1957

[4] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].

Amin, Mahul B. ;

Greene, Frederick L. ;

Edge, Stephen B. ;

Compton, Carolyn C. ;

Gershenwald, Jeffrey E. ;

Brookland, Robert K. ;

Meyer, Laura ;

Gress, Donna M. ;

Byrd, David R. ;

Winchester, David P. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99

[5]

[Anonymous], 2021, EUR J SURG ONCOL, V47, P1481

[6] Surgeon volume and operative mortality in the United States [J].

Birkmeyer, JD ;

Stukel, TA ;

Siewers, AE ;

Goodney, PP ;

Wennberg, DE ;

Lucas, FL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2117-2127

[7] Hospital volume and surgical mortality in the United States. [J].

Birkmeyer, JD ;

Siewers, AE ;

Finlayson, EVA ;

Stukel, TA ;

Lucas, FL ;

Batista, I ;

Welch, HG ;

Wennberg, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1128-1137

[8] Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis [J].

Boshier, P. R. ;

Heneghan, R. ;

Markar, S. R. ;

Baracos, V. E. ;

Low, D. E. .

DISEASES OF THE ESOPHAGUS, 2018, 31 (08)

[9] Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J].

Bosset, JF ;

Gignoux, M ;

Triboulet, JP ;

Tiret, E ;

Mantion, G ;

Elias, D ;

Lozach, P ;

Ollier, JC ;

Pavy, JJ ;

Mercier, M ;

Sahmoud, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :161-167

[10] The Clavien-Dindo Classification of Surgical Complications Five-Year Experience [J].

Clavien, Pierre A. ;

Barkun, Jeffrey ;

de Oliveira, Michelle L. ;

Vauthey, Jean Nicolas ;

Dindo, Daniel ;

Schulick, Richard D. ;

de Santibanes, Eduardo ;

Pekolj, Juan ;

Slankamenac, Ksenija ;

Bassi, Claudio ;

Graf, Rolf ;

Vonlanthen, Rene ;

Padbury, Robert ;

Cameron, John L. ;

Makuuchi, Masatoshi .

ANNALS OF SURGERY, 2009, 250 (02) :187-196

← 1 2 3 4 5 →